Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for lung cancer patients whose current drugs fail

NCT ID NCT06195189

Recruiting now Disease control Sponsor: Sichuan University Source: ClinicalTrials.gov ↗

First seen May 11, 2026 · Last updated May 16, 2026 · Updated 2 times

Summary

This study tests a new drug called sunvozertinib combined with chemotherapy in people with advanced non-small cell lung cancer that has a specific gene change (EGFR mutation) and has stopped responding to standard targeted therapy. About 40 adults will receive the combination to see if it can shrink tumors and how safe it is. The goal is to control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610044, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER